🇺🇸 FDA
Patent

US 9446114

Cross-protective arenavirus vaccines and their method of use

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 9446114 (Cross-protective arenavirus vaccines and their method of use) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K39/12, A61P